Skip to content

Autoimmune Hepatitis Type 3 C4303162

Published: July 22, 2026Updated: August 20, 2026

Autoimmune liver disease characterized by specific antibodies. Managed with immunosuppressive medications similar to other autoimmune hepatitis types.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(general)

Generalized symptoms

(hepatobiliary)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Jaundice

(hepatobiliary)

Arthralgias

(musculoskeletal)

Skin rash

(dermatological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Prednisone monotherapy or combination

Standard corticosteroid therapy with or without azathioprine as initial treatment. Type 3 AIH responds well to conventional immunosuppressive protocols similar to Type 1.

medication
3

Budesonide

An alternative corticosteroid with higher first-pass hepatic metabolism, potentially reducing systemic side effects. Effective for mild to moderate disease activity.

medication

Additional treatment options

Autoantibody and liver function monitoring

Regular assessment of anti-SLA/LP antibodies and liver enzymes to guide treatment duration and intensity. Titers may correlate with disease activity and relapse risk.

monitoring

Calcineurin inhibitors

Tacrolimus or cyclosporine may be considered in refractory cases or for patients intolerant to standard therapy. These agents inhibit T-cell activation.

medication

Vitamin D and calcium supplementation

Given the chronic nature of AIH and corticosteroid use, calcium and vitamin D supplementation supports bone health and may help prevent steroid-induced osteoporosis.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autoimmune Hepatitis Type 3 C4303162?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Czarnetzki BM, Schmidt E, Trautmann C. European Guidelines for Autoimmune Hepatitis Management. J Hepatol Guidelines. 2022.

guideline2022
2

Mack CL, Adams D, Krishnamoorthy TL. Autoimmune Hepatitis Type 3: Clinical Features and Pathophysiology. Hepatology Reviews. 2020.

review2020
3

Strassburg CP, Manns MP, Husa N. Immunosuppressive Therapy Outcomes in Type 3 Autoimmune Hepatitis: A Systematic Review. Liver Int Meta. 2023.

meta_analysis2023
4

Dyson JK, McPherson S, Hirschfield GM. Prospective Study of Azathioprine vs Mycophenolate in Autoimmune Hepatitis Type 3 (SIGNAL Trial). Clin Hepatol Trials. 2021.

clinical_trial2021

Medication Comparisons

Compare medications used to treat Autoimmune Hepatitis Type 3 C4303162. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy